Viewing Study NCT05816356


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-31 @ 5:47 AM
Study NCT ID: NCT05816356
Status: COMPLETED
Last Update Posted: 2025-05-22
First Post: 2023-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
Sponsor: EpiDestiny, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EPI-01A-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View